首页> 外文期刊>臨床血液 >Complete cytogenetic response obtained with unrelated donor lymphocyte infusion for relapse of chronic myeloid leukemia in blastic crisis after allogeneic bone marrow transplantation
【24h】

Complete cytogenetic response obtained with unrelated donor lymphocyte infusion for relapse of chronic myeloid leukemia in blastic crisis after allogeneic bone marrow transplantation

机译:在同种异体骨髓移植后,用不相关的供体淋巴细胞输注进行了完全的细胞遗传学反应,用于复发慢性骨髓白血病

获取原文
获取原文并翻译 | 示例
       

摘要

A 35-year-old man with chronic myeloid leukemia (CML) in blastic crisis (BC) received an allogeneic bone marrow transplant from an unrelated donor in October 1998 after three cycles of chemotherapy. BC relapse developed on day 349 after transplantation. After one cycle of chemotherapy and treatment with interferon, the patient received donor lymphocyte infusion (DLI), and this resulted in a complete cytogenetic response 21 days later. Grade III acute graft-versus-host disease developed on day 25 after DLI, but this was resolved after administration of prednisolone. Disease relapse occurred at extramedullary sites on day 162 after DLI, and the patient died of sepsis after receiving chemotherapy. This case illustrates that unrelated DLI can induce remission successfully in patients with relapse of CML in BC through a graft-versus-leukemia effect.
机译:一名35岁的男子患有慢性骨髓白血病(CML)的骨髓危机(BC),1998年10月在三个循环化疗后,1998年10月的一个异种骨髓移植。 BC复发在移植后第349天开发。 在一个化疗和干扰素治疗的循环后,患者接受了供体淋巴细胞输注(DLI),这导致21天后完全的细胞遗传学反应。 III级急性接枝 - 与宿主疾病在DLI后第25天开发,但在泼尼松酮施用后解决了这一点。 在DLI后第162天的次蛋白位置发生疾病复发,并且在接受化疗后,患者死于败血症。 这种情况说明了通过移植物与白血病效应,在BC中复制CML的患者中,无关的DLI可以成功诱发缓解。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号